12/18/2025
We’re exploring extracellular protein degradation, a new way to target the proteins driving disease at their source. Our goal is to develop therapies that are precise, patient-focused and designed with accessibility in mind, helping people living with immune-mediated diseases get the care they need: https://bit.ly/3JY6bod